Abstract

Many putative uremic toxins—like indoxyl sulfate, p-cresol sulfate, kynurenic acid, uric acid, and CMPF—are organic anions. Both inter-organ and inter-organismal communication are involved. For example, the gut microbiome is the main source of indole, which, after modification by liver drug metabolizing enzymes (DMEs), becomes indoxyl sulfate. Various organic anion transporters (organic anion transporters, OATs; organic anion-transporting polypeptides, OATPs; multidrug resistance-associated proteins, MRPs, and other ABC transporters like ABCG2)—often termed “drug transporters”—mediate movement of uremic toxins through cells and organs. In the kidney proximal tubule, critical roles for OAT1 and OAT3 in regulating levels of protein-bound uremic toxins have been established using knock-out mice. OATs are important in maintaining residual tubular function in chronic kidney disease (CKD); as CKD progresses, intestinal transporters like ABCG2, which extrude urate and other organic anions into the gut lumen, seem to help restore homeostasis. Uremic toxins like indoxyl sulfate also regulate signaling and metabolism, potentially affecting gene expression in extra-renal tissues as well as the kidney. Focusing on the history and evolving story of indoxyl sulfate, we discuss how uremic toxins appear to be part of an extensive “remote sensing and signaling” network—involving so-called drug transporters and drug metabolizing enzymes which modulate metabolism and signaling. This systems biology view of uremic toxins is leading to a new appreciation of uremia as partly due to disordered remote sensing and signaling mechanisms–resulting from, and causing, aberrant inter-organ (e.g., gut-liver- kidney-CNS) and inter-organismal (e.g., gut microbiome-host) communication.

Highlights

  • There is a new appreciation of the role of the kidney in organ cross-talk and inter- organismal communication mediated by small organic molecules

  • Many of these molecules are organic anions transported by renal (e.g., OAT1) and non-renal transporters (OATP1B1) and altered by Phase 1 and Phase 2 drug metabolizing enzymes (DMEs); many of these molecules have well-described roles in metabolism, signaling, and modulation of redox state [1]. Among these are so-called protein-bound uremic toxins, which accumulate in chronic kidney disease (CKD) as tubular secretion declines

  • It was observed that spiking control plasma with indoxyl sulfate to a concentration typical of that observed in patients with endstage renal disease (ESRD), simulated roughly 80% of the dysregulation observed with uremic plasma (Figures 1C–E)

Read more

Summary

Uremic Toxins in Organ Crosstalk

Edited by: Frederic Jaisser, Institut National de la Santé et de la Recherche Médicale (INSERM), France. Reviewed by: Gautam Bhave, Vanderbilt University, United States Leslie Stuart Gewin, Vanderbilt University, United States. Specialty section: This article was submitted to Nephrology, a section of the journal

Frontiers in Medicine
INTRODUCTION
THE MANY FACES OF INDOXYL SULFATE
INDOXYL SULFATE SIGNALING AND THE REMOTE SENSING AND SIGNALING THEORY
ALTERED REMOTE SENSING AND SIGNALING IN CKD
Findings
WHAT ORCHESTRATES THE SYSTEM?
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.